BIO Europe 2019


Pharmahungary Group representative attended the 25th BIO-Europe conference in Hamburg, Germany between November 11-13, 2019.

Founder & CEO attended several business meetings and introduced Pharmahungary Group innovative:

preclinical R&D services, from cells to large animal models focusing on cardiovascular, metabolic, renal, and inflammation disease models

clinical R&D services, focusing on but not limited to clinical trials with Medical Devices, In Vitro Diagnostics, AMTPs, and niche trials that need strong scientific and regulatory support due to e.g. sensitive patient population

–  innovative in-house R&D projects: early stage drug-development projects, In Vitro Diagnostics, drug-discovery enabling technologies